---
title: "Genotyping data and genetic risk score processing and delivery services"
ocid: "ocds-h6vhtk-02f7f2"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7f2"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02f7f2.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02f7f2.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "OUR FUTURE HEALTH (AKESO ACTING ON BEHALF OF)"
published: "2021-11-18"
---

# Genotyping data and genetic risk score processing and delivery services

Buyer: OUR FUTURE HEALTH (AKESO ACTING ON BEHALF OF)  
Current stage: Planning  
OCID: ocds-h6vhtk-02f7f2

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7f2)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02f7f2.json)

## Summary

The procurement process titled "Genotyping data and genetic risk score processing and delivery services" is being organised by Our Future Health, based in Manchester, UK. This procurement falls under the category of data analysis services and is currently at the planning stage, with a focus on gathering market feedback regarding viable solutions. Key dates include a deadline for expressions of interest by 1st December 2021, followed by a market engagement briefing session on 8th December 2021, where further details will be shared. The procurement method is tendering, which is governed by the Public Contract Regulations 2015.

This tender presents significant opportunities for businesses in the bioinformatics and data analysis sectors, especially those specialising in genetic data processing and related services. Companies that provide innovative solutions for managing genotyping data, developing risk computation tools, and offering genetic counselling would be particularly well-suited to compete. The scale of this programme, aiming to build the UK's largest health research cohort, opens avenues for growth and collaboration in health research and technology development.

## Notice

Our Future Health is seeking to engage the market and gain feedback on viable solutions for processing genotyping data including quality control, ancestry and relatedness analysis, imputation of additional genotypes, and calculation and delivery of polygenic risk scores or other genetic prediction models including genetic counselling services.

### Lot Information

Lot 1

Our Future Health will be the UK's largest ever health research programme, aiming to build a cohort of five million people from all backgrounds and from right across the UK. Participants will be asked to complete an online questionnaire about their lifestyle and medical history and to provide a blood sample, from which DNA will be extracted and used to obtain genetic data. Our Future Health will ask for permission to combine the information and samples provided with existing information about them, including their health records. Adding these additional types of information will help to build a more comprehensive picture of health and wellbeing that could be relevant to understanding what changes people's risk of disease. Combining these multiple sources of health and health-relevant information, including genetic data, will create an incredibly detailed picture that represents the whole of the UK. Researchers will use this information to make new discoveries about human health and diseases. Our Future Health will use the health information, including genetic data, to calculate disease risk scores for its participants. Based on these risk profiles, it might be possible to better identify individuals who are at higher risk of developing certain diseases. This will provide an opportunity to test the potential of new diagnostic tests or treatments as they are discovered and to see how effective they could be for people at higher risk of certain diseases. This will also mean Our Future Health can facilitate research addressing important questions about the potential uses of genetic risk scores in health care. Our Future Health expects genetic data to become available from mid-2022 and is now seeking to engage market providers of bioinformatics services to define requirements and capabilities relating to: A scalable pipeline for genotyping data management, including individual, variant and batch quality control, and basic ancestry and relatedness analysis - Robust and scalable imputation of additional variants using UK-wide reference panels with diverse ancestry - Calculation of genetic risk scores (polygenic risk scores) - Risk communication tools suitable for delivery of genetic risk score results to participants - Genetic counselling or educational or other services suitable to support participants' informed decision-making regarding genetic information - Calculation and presentation of genetic ancestry Our Future Health are reviewing potential lot structures for this procurement and will be seeking feedback during the market engagement process. Additional information: Providers in this market are invited to express interest in this procurement activity by email to ourfuturehealth@akesoco.com by Wednesday 1st December 2021. On receipt of expression of interest, providers will be asked to respond to a short questionnaire to gather information on optimal solutions for the service in advance of being invited to a briefing session on 8th December at 15:00-16:00 GMT, to describe the requirement and expectation of the service of the market in more detail.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/028803-2021 |
| Notice type | Planning Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 18 Nov 2021 |
| Submission deadline | Not specified |
| Future notice date | 14 Feb 2022 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | OUR FUTURE HEALTH (AKESO ACTING ON BEHALF OF) |
| Locality | MANCHESTER |
| Post town | Not specified |
| Postcode | N/A |
| Country | Not specified |
| ITL 1 | Not specified |
| ITL 2 | Not specified |
| ITL 3 | Not specified |
| Local authority | Not specified |
| Electoral ward | Not specified |
| Westminster constituency | Not specified |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLG West Midlands (England), TLK South West (England), TLL Wales, TLN Northern Ireland |

## CPV Codes

### Divisions

- 72 - IT services: consulting, software development, Internet and support
- 73 - Research and development services and related consultancy services

### Codes

- 72316000 - Data analysis services
- 73110000 - Research services

## Release History

- 18 Nov 2021 at 12:32 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/028803-2021

## Notice URLs

- http://www.ourfuturehealth.org.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7f2. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02f7f2.json.
